Rapid improvement in spasticity, post-stroke pain, walking, vision, hearing, and fatigue after PSE treatment by Dr. Tobinick, 3 years after stroke. Filmed on September 26, 2024 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Patient from Canada exhibits multiple improvements in post-stroke pain, sensation, spasticity, vision, fatigue, and taste after PSE treatment by Dr. Tobinick, 2 years after stroke. Filmed on September 24, 2024 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Immediate improvement in chronic post-stroke pain, vision, balance, and fatigue after PSE treatment by Danielle Ucci, PA-C, 4 years after stroke. Filmed on September 13, 2024 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Dramatic improvement in bladder control, swallowing, and mobility after PSE treatment, 8 years after stroke. Filmed on September 11, 2024 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Improvements in left neglect, post-stroke pain, cognition, balance, vision, and spasticity after PSE treatment by Dr. Tobinick. Filmed on August 29, 2024 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0